| Role |
Name |
Disclosure |
Details |
| Author | John H Raaf, MD, PhD, Professor, Department of Surgery, Case Western University | Nothing to disclose | Details | | Coauthor | Anastasios K Konstantakos, MD, Clinical Associate Surgeon, Brigham and Women's Hospital, Harvard University | Nothing to disclose | Details | | Coauthor | Heather N Raaf, MD, Chief Deputy Coroner, Cuyahoga County Coroner's Office (Retired) | Nothing to disclose | Details | | Medical Editor | Robert C Shepard, MD, FACP, Associate Professor of Medicine in Hematology and Oncology at University of North Carolina at Chapel Hill; Vice President of Scientific Affairs, Therapeutic Expertise, Oncology, at PRA International | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | CME Editor | Rajalaxmi McKenna, MD, FACP, Consulting Staff, Department of Medicine, Southwest Medical Consultants, SC, Good Samaritan Hospital, Advocate Health Systems | Nothing to disclose | Details | | Chief Editor | Jules E Harris, MD, Visiting Professor of Medicine, Division of Hematology/Medical Oncology, Department of Internal Medicine, University of Arizona College of Medicine at Tucson; Consulting Staff, Arizona Cancer Center | GlobeImmune Amplimed | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Anastasios K Konstantakos, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Robert C Shepard, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Rajalaxmi McKenna, CME Editor |
The contributor discloses no conflict of interest. |
|